178 related articles for article (PubMed ID: 21922169)
1. Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills.
Verster JC; Roth T
Psychopharmacology (Berl); 2012 Mar; 220(2):293-301. PubMed ID: 21922169
[TBL] [Abstract][Full Text] [Related]
2. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
Verster JC; Volkerts ER; Verbaten MN
Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment.
Verster JC; Roth T
Accid Anal Prev; 2012 Mar; 45():498-506. PubMed ID: 22269535
[TBL] [Abstract][Full Text] [Related]
4. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
[TBL] [Abstract][Full Text] [Related]
5. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.
Iwata M; Iwamoto K; Kitajima I; Nogi T; Onishi K; Kajiyama Y; Nishino I; Ando M; Ozaki N
Psychopharmacology (Berl); 2021 Mar; 238(3):775-786. PubMed ID: 33236169
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
Ramaekers JG
J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic.
Ramaekers G; Lamers J; Verhey F; Muntjewerff D; Mobbs E; Sanders N; Lewis M; Lockton A
Psychopharmacology (Berl); 2002 Jan; 159(2):203-10. PubMed ID: 11862350
[TBL] [Abstract][Full Text] [Related]
9. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
10. Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.
Vinckenbosch FRJ; Vermeeren A; Verster JC; Ramaekers JG; Vuurman EF
Psychopharmacology (Berl); 2020 Mar; 237(3):877-886. PubMed ID: 31897572
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
[TBL] [Abstract][Full Text] [Related]
12. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
Kuypers KP; Samyn N; Ramaekers JG
Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
[TBL] [Abstract][Full Text] [Related]
13. Visual attention outperforms visual-perceptual parameters required by law as an indicator of on-road driving performance.
Grundler W; Strasburger H
PLoS One; 2020; 15(8):e0236147. PubMed ID: 32797082
[TBL] [Abstract][Full Text] [Related]
14. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation.
Jongen S; Perrier J; Vuurman EF; Ramaekers JG; Vermeeren A
PLoS One; 2015; 10(2):e0117045. PubMed ID: 25668292
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
Verster JC; Roth T
J Clin Psychopharmacol; 2014 Oct; 34(5):633-6. PubMed ID: 24978156
[TBL] [Abstract][Full Text] [Related]
17. Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients.
Veldhuijzen DS; van Wijck AJ; Verster JC; Kenemans JL; Kalkman CJ; Olivier B; Volkerts ER
J Psychopharmacol; 2006 Nov; 20(6):782-8. PubMed ID: 16401650
[TBL] [Abstract][Full Text] [Related]
18. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo.
Theunissen EL; Vermeeren A; van Oers AC; van Maris I; Ramaekers JG
Clin Exp Allergy; 2004 Feb; 34(2):250-8. PubMed ID: 14987305
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
[TBL] [Abstract][Full Text] [Related]
20. Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP).
Verster JC; Roth T
Int J Gen Med; 2011; 4():359-71. PubMed ID: 21625472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
